Show simple item record

BehÇet's Disease

dc.contributor.authorWong, Reynold C.en_US
dc.contributor.authorEllis, Charles N.en_US
dc.contributor.authorDiaz, Luis A.en_US
dc.date.accessioned2010-04-01T15:37:08Z
dc.date.available2010-04-01T15:37:08Z
dc.date.issued1984-01en_US
dc.identifier.citationWong, Reynold C.; Ellis, Charles N.; Diaz, Luis A. (1984). "BehÇet's Disease." International Journal of Dermatology 23(1): 25-32. <http://hdl.handle.net/2027.42/66106>en_US
dc.identifier.issn0011-9059en_US
dc.identifier.issn1365-4632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/66106
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6373632&dopt=citationen_US
dc.format.extent1174134 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1984 Blackwell Science Ltden_US
dc.titleBehÇet's Diseaseen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumImmunodermatology Unit, University of Michigan School of Medicine, and the Veterans Administration Medical Center, Ann Arbor, Michiganen_US
dc.identifier.pmid6373632en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/66106/1/j.1365-4362.1984.tb05658.x.pdf
dc.identifier.doi10.1111/j.1365-4362.1984.tb05658.xen_US
dc.identifier.sourceInternational Journal of Dermatologyen_US
dc.identifier.citedreferenceMÚftÚoglu AÜ : Symposium on the hematological and immunological aspects of BehÇet's disease: opening remarks. Haematologica 65 : 374, 1980.en_US
dc.identifier.citedreferenceShimizu T, Ehrlich GE, Inaba G, et al: BehÇet disease (BehÇet syndrome). Sem Arthr Rheumatism 8 : 223. 1979.en_US
dc.identifier.citedreferenceCallen JP : BehÇet's syndrome. In : Cutaneous Aspects of Internal Medicine. Edited by Callen JP. Chicago, Year Book Medical Publishers, 1981, p 93.en_US
dc.identifier.citedreferenceChajek T, Fainaru M : BehÇet's disease. In : Clinical Immunology. Edited by Parker CW. Philadelphia, WB Saunders, 1980, p 667.en_US
dc.identifier.citedreferenceO'Duffy JD : BehÇet's disease. In : Textbook of Rheumatology. Edited by Kelly WB, et al. Philadelphia, WB Saunders, 1981, p 1197.en_US
dc.identifier.citedreferenceMason RM, Barnes CG : BehÇet's syndrome with arthritis. Ann Rheum Dis 28 : 95, 1969.en_US
dc.identifier.citedreferenceO'Duffy JD, Goldstein NP : Neurologic involvement in seven patients with BehÇet's disease. Am J Med 61 : 170, 1976.en_US
dc.identifier.citedreferenceCupps TR, Fauci AS : The Vasculitides, Philadelphia, WB Saunders, 1981.en_US
dc.identifier.citedreferenceWright VA. Chamberlain MA : BehÇet's syndrome. Bull Rheum Dis 29 : 972. 1978–79.en_US
dc.identifier.citedreferenceTÜzÜn Y. AltaÇ M, Yazici H. et al: Nonspecific skin hyperreactivity in BehÇet's disease. Haematologica 65 : 395, 1980.en_US
dc.identifier.citedreferenceO'Duffy JD, Carney JA, Deodhar S : BehÇet's disease: report of 10 cases, 3 with new manitestations. Ann Int Med 75 : 561, 1971.en_US
dc.identifier.citedreferenceKalbian VV, Challis MT : BehÇet's disease: report of twelve cases with three manifesting as papilledema. Am I Med, 49 : 823, 1970.en_US
dc.identifier.citedreferenceTÜzÜn Y, Yazici H, Pazarli H, et al: The usefulness of the nonspecitic skin hyperreactivity (the pathergy test) in BehÇet's disease in Turkey. Acta Derm Venereol 59 : 77, 1979.en_US
dc.identifier.citedreferenceHaim S, Gilham A : Clinical and laboratory criteria for the diagnosis of BehÇet's disease. Br J Dermatol 102 : 361, 1980.en_US
dc.identifier.citedreferenceMamo JG : Treatment of BehÇet disease with chlorambucil. Arch Ophthalmol 94 : 580, 1976.en_US
dc.identifier.citedreferenceJames DG : BehÇet's syndrome. N Engl J Med 301 : 431, 1979.en_US
dc.identifier.citedreferenceMarquardt JL, Synderman R, Oppenheim JJ : Depression of lymphocyte transformation and exacerbation of BehÇet's syndrome by ingestion of English walnuts. Cell Imm 9 : 263, 1973.en_US
dc.identifier.citedreferenceOshima Y, Shimizu T, Yokohari R, et al: Clinical studies on BehÇet's syndrome. Ann Rheum Dis 22 : 36, 1963.en_US
dc.identifier.citedreferenceAbdou Nl, Schumacher HR, Colman RW, et al: BehÇet's disease: possible role of secretory component deficiency, synovial inclusions, and fibrinolytic abnormality in the various manifestations of the disease. J Lab Clin Med 91 : 409, 1978.en_US
dc.identifier.citedreferenceGupta RC, O'Duffy JD, McDuffie FC, et al: Circulating immune complexes in active BehÇet's disease. Clin Exp Immunol 34 : 213, 1978.en_US
dc.identifier.citedreferenceLehner T : Progress report: oral ulceration and BehÇet's syndrome. Gut 18 : 491, 1977.en_US
dc.identifier.citedreferenceLevinsky RJ, Lehner T : Circulating soluble immune complexes in recurrent oral ulceration and BehÇet's syndrome. Clin Exp Immunol 32 : 193, 1978.en_US
dc.identifier.citedreferenceLehner T, Almeida JD, Levinsky RJ : Damaged membrane fragments and immune complexes in the blood of patients with BehÇet's syndrome. Clin Exp Immunol 34 : 206, 1978.en_US
dc.identifier.citedreferenceRogers RS, Sams WM, Shorter RG : Lymphocytotoxicity in recurrent aphthous stomatitis: lymphocytotoxicity for oral epithelial cells in recurrent aphthous stomatitis and BehÇet's syndrome. Arch Dermatol 109 : 361, 1974.en_US
dc.identifier.citedreferenceLehner T : Stimulation of lymphocyte transformation by tissue homogenates in recurrent oral ulceration. Immunology 13 : 159, 1967.en_US
dc.identifier.citedreferenceLehner T, Adinolfi M : Acute phase proteins, C9, factor B, and lysozyme in recurrent oral ulceration and BehÇet's syndrome. J Clin Pathol 33 : 269, 1980.en_US
dc.identifier.citedreferenceAlm L, Oberg L : Animal experiment in connection with BehÇet's syndrome: preliminary report. Nord Med (Hygiea) 25 : 603, 1945.en_US
dc.identifier.citedreferenceSezer FN : The isolation of a virus as the cause of BehÇet's disease. Am J Ophthalmol 36 : 301, 1953.en_US
dc.identifier.citedreferenceSezer FN : Further investigations on the virus of BehÇet's disease. Am J Ophthalmol 41 : 41, 1956.en_US
dc.identifier.citedreferenceEvans AD, Pallis CA, Spillane JD : Involvement of the nervous system in BehÇet's syndrome: report of three cases and isolation of virus. Lancet ii : 349, 1957.en_US
dc.identifier.citedreferenceMortada A, Iman ZEI : Virus aetiology of BehÇet's syndrome. Br J Ophthal 48 : 250, 1964.en_US
dc.identifier.citedreferenceDenman AM, Fialkow PJ, Pelton BK, et al: Lymphocyte abnormalities in BehÇet's syndrome. Clin Exp Immunol 42 : 175, 1980.en_US
dc.identifier.citedreferenceCurth HO : Recurrent genito-oral aphthosis and uveitis with hypopyon (BehÇet's syndrome): report of two cases. Arch Dermatol Syphilol 54 : 179, 1976.en_US
dc.identifier.citedreferenceBreslin, HJ : BehÇet's disease: report of a case history of seventeen years' duration. Am J Ophthalmol 53 : 132, 1962.en_US
dc.identifier.citedreferenceFrance R, Buchanan RN, Wilson MW, et al: Relapsing iritis with recurrent ulcers of the mouth and genitalia (BehÇet's syndrome). Medicine 30 : 335, 1951.en_US
dc.identifier.citedreferenceKatzenellenbogen I : Recurrent aphthous ulceration of oral mucous membtane and genitals associated with recurrent hypopyon iritis (BehÇet's syndrome): report of three cases. Br l Dermatol 58 : 161, 1946.en_US
dc.identifier.citedreferenceDudgeon JA : Virological aspects of BehÇet's disease. Proc R Soc Med 54 : 104, 1961.en_US
dc.identifier.citedreferenceChajek T, Fainaru M : BehÇet's disease. Report of 41 cases and a review of the literature. Medicine 54 : 179, 1975.en_US
dc.identifier.citedreferenceGraykowski EA, Kingman A : Double-blind trial of tetracycline in recurrent aphthous ulceration. J Oral Pathol 7 : 376, 1978.en_US
dc.identifier.citedreferenceAddy M, Tapper-Jones L, Seal M : Trial of astringent and antibacterial mouthwashes in the management of recurrent aphthous ulceration. Br Dent l 136 : 452, 1974.en_US
dc.identifier.citedreferenceO'Duffy JD : BehÇet's syndrome: comments. Bull Rheum Dis 29 : 977, 1978–79.en_US
dc.identifier.citedreferenceNethercott J, Lester RS : Azathioprine therapy in incomplete BehÇet's syndrome. Arch Dermatol 110 – 432, 1974.en_US
dc.identifier.citedreferenceBietti GB. Cerulli L, Pivetti-Pizzi P : BehÇet's disease and immunosuppressive treatment. Mod Probl Ophthal 16 : 314, 1976.en_US
dc.identifier.citedreferenceMamo JG, Azzam SA : Treatment of BehÇet's disease with chlorambucil. Arch Ophthalmol 84 : 446, 1970.en_US
dc.identifier.citedreferenceAoki K, Sugiura S : Immunosuppressive treatment of BehÇet's disease. Mod Probl Ophthal 16 : 309, 1976.en_US
dc.identifier.citedreferenceBuckley CE III, Gills JP Jr : Cyclophosphamide therapy of BehÇet's disease. J Allergy 43 : 273, 1969.en_US
dc.identifier.citedreferenceScarlett JA. Kistner ML, Yang LC : BehÇet's syndrome: report of a case associated with pericardial effusion and cryoglobulinemia treated with indomethacin. Am J Med 66 : 146, 1979.en_US
dc.identifier.citedreferenceSymoens J, Rosenthal M : Levamisole in the modulation of the immune response: the current experimental and clinical state. J Reticuloendothelial Soc 21 : 175, 1977.en_US
dc.identifier.citedreferenceBier RE, George B. Wilson T, et al : Evaluation of the therapeutic effect of levamisole in treatment of recurrent aphthous stomatitis. J Oral Pathol 7 : 405, 1978.en_US
dc.identifier.citedreferenceDrinnan AJ. Fischman SL : Randomized, double-blind study of levamisole in recurrent aphthous stomatitis. J Oral Pathology 7 : 414, 1978.en_US
dc.identifier.citedreferenceDe Merieux P, Spitler LE, Paulus HE : Treatment of BehÇet's syndrome with levamisole. Arth Rheumatism 24 : 64, 1981.en_US
dc.identifier.citedreferenceMatsumura N, Mizushima Y : Leukocyte movement and colchicine treatment in BehÇet's disease. Lancet ii : 813, 1975.en_US
dc.identifier.citedreferenceAktulga E, AltaÇ M. MÜftÜoglu A, et al : A double blind study of colchicine in BehÇet's disease. Haematologica 65 : 399, 1980.en_US
dc.identifier.citedreferenceMizushima Y, Matsumura N, Mori M, et al : Colchicine in BehÇet's disease. Lancet ii : 1037, 1977.en_US
dc.identifier.citedreferenceMiyachi Y, Taniguchi S. Ozaki M, et al : Colchicine in the treatment of the cutaneous manifeslations of BehÇet's disease. Br J Dermatol 104 : 67, 1981.en_US
dc.identifier.citedreferenceHazen PG, Michel B : Management of necrotizing vaseulitis with colchicine. Arch Dermatol 115 : 1303, 1979.en_US
dc.identifier.citedreferenceRaynor A, Askari AD : BehÇet's disease and treatment with colchine. J Am Acad Dermatol 2 : 396, 1980.en_US
dc.identifier.citedreferenceCunliffe WJ, Roberts BE, Dodman B : BehÇet's syndrome and oral fibrinolytic therapy. Br Med J 2 : 486, 1973.en_US
dc.identifier.citedreferenceNewland AC, Wood MJ : BehÇet's disease. Br Med J 2 : 1163, 1978.en_US
dc.identifier.citedreferenceCunliffe WJ, Menon J S : Treatment of BehÇet's syndrome with phenformin and ethyloestrenol. Lancet i : 1239, 1969.en_US
dc.identifier.citedreferenceWolf RE, Fundenberg H, Welch TM, et al : Treatment's of BehÇet's syndrome with transfer factor. JAMA 238 : 869, 1977.en_US
dc.identifier.citedreferenceBernhard GC, Heim LR : Transfer factor treatment of BehÇet's syndrome, abstracted. J Rheumatol 1 : 34, 1974.en_US
dc.identifier.citedreferenceHaim S, Sherf K : BehÇet's disease: presentation of 11 cases and evaluation of treatment. Israel J Med Sci 2 : 69, 1966.en_US
dc.identifier.citedreferenceO'Duffy JD, Taswell HF : Blood transfusion therapy in BehÇet's disease. Ann Int Med 80 : 279, 1974.en_US
dc.identifier.citedreferenceMichaud RM, Hathaway DE : BehÇet's disease and fresh whole blood transfusion. J Assoc Mil Dermatol 7 : 30, 1981.en_US
dc.identifier.citedreferenceTager A : Preliminary report of the treatment of BehÇet's syndrome with oral poliomyelitis vaccine (Sabin). Dermatologica 152 : 372, 1976.en_US
dc.identifier.citedreferenceFishel B, Tager A, Fishel R, et al : Poliomyelitis vaccine in the treatment of BehÇet's syndrome. Arch Dermatol 116 : 1348, 1980.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.